Cargando…
Insights into the use of mesenchymal stem cells in COVID-19 mediated acute respiratory failure
The emergence of severe acute respiratory syndrome corona virus 2 (SARS-CoV-2) at the end of 2019 in Hubei province China, is now the cause of a global pandemic present in over 150 countries. COVID-19 is a respiratory illness with most subjects presenting with fever, cough and shortness of breath. I...
Autores principales: | Durand, Nisha, Mallea, Jorge, Zubair, Abba C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589470/ https://www.ncbi.nlm.nih.gov/pubmed/33580031 http://dx.doi.org/10.1038/s41536-020-00105-z |
Ejemplares similares
-
Effect of Comedications and Endotoxins on Mesenchymal Stem Cell Secretomes, Migratory and Immunomodulatory Capacity
por: Durand, Nisha, et al.
Publicado: (2019) -
Feasibility and Safety of Low-Dose Mesenchymal Stem Cell Infusion in Lung Transplant Recipients
por: Erasmus, David Brett, et al.
Publicado: (2022) -
Feasibility, potency, and safety of growing human mesenchymal stem cells in space for clinical application
por: Huang, Peng, et al.
Publicado: (2020) -
Challenges and translational considerations of mesenchymal stem/stromal cell therapy for Parkinson’s disease
por: Fričová, Dominika, et al.
Publicado: (2020) -
Cell‐based therapy to reduce mortality from COVID‐19: Systematic review and meta‐analysis of human studies on acute respiratory distress syndrome
por: Qu, Wenchun, et al.
Publicado: (2020)